”The results are striking,” said Professor Roberto Bolli, one of the research leaders from the University of Louisville in the US. ”While we do not yet know why the improvement occurs, we have no doubt now that ejection fraction increased and scarring decreased.
”If these results hold up in future studies, I believe this could be the biggest revolution in cardiovascular medicine in my lifetime.”
A total of 23 patients took part in the ”Scipio” trial, all of whom had suffered heart failure due to a previous heart attack. Sixteen were assigned to the stem cell therapy while the other seven received standard care.
Given how dramatic it is, it seems almost unethical to treat the others in any other way.
I’m hoping that I won’t need this, but given my family history, I may. Anyway, I’m glad it’s coming along.
Adult stem cells, needless to say.